MindWalk Holdings (HYFT) EBT Margin Growth (1y) (2021 - 2026)

MindWalk Holdings (HYFT) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -153.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -571.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 452.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1,076.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -9,422.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -392.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1,911.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,565.00
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -801,907.00

Historic Data

Download Data
DateValue
Apr 30, 2026 0.00
Jan 31, 2026 -77,213.00
Oct 31, 2025 -8,888.00
Jul 31, 2025 9.13 Mn
Apr 30, 2025 -53,698.00
Jan 31, 2025 72,210.00
Oct 31, 2024 -3.16 Mn
Jul 31, 2024 -8.05 Mn
Apr 30, 2024 134,276.00
Jan 31, 2024 3,113.00
Oct 31, 2023 3.16 Mn
Jul 31, 2023 8.06 Mn
Apr 30, 2023 -45,289.00
Jan 31, 2023 1,847.00
Oct 31, 2022 22,162.00
Jul 31, 2022 7,265.00
Apr 30, 2022 7.18 Bn
Jan 31, 2022 2,903.00
Oct 31, 2021 -6,339.00
Jul 31, 2021 -4,250.00